
U.S.-listed shares of contact lens maker Bausch + Lomb's BLCO.TO, BLCO.N fall 15.6% to $11.6, hitting all-time low
Stock set for its worst day ever, if losses hold
BLCO posts Q1 adj. loss of 15 cents per share, compared with analysts' estimated profit of 3 cents per share, according to data compiled by LSEG
Co reports Q1 revenue of $1.14 billion vs estimates of $1.15 billion
However, co raised its annual revenue forecast to the range of $5 billion to $5.1 billion compared to the previous projection of $4.95 billion to $5.05 billion
Brokerage Evercore ISI says "while we expected annual forecast cut on enVista recall and tariffs, the Q1 margin and EPS miss was unexpected"
*Brokerage believes BLCO "needs to demonstrate consistency in earnings and margins, and volatility in some of these metrics is not helping the stock"
As of last close, BLCO has fallen 36% YTD